Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
Brain changes related to Huntington's evident on imaging decades before symptoms emerge
Experts hope their findings offer valuable insights that one day lead to improved interventions aimed at preserving brain function in patients with Huntington's.
Medtronic heart rhythm technologies on full display at AF Symposium 2025
Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston.

Pfizer CEO: Expecting pharma to fight COVID for free ‘very fanatic and radical’

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Evolocumab use benefits people living with HIV, dyslipidemia patients

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here?

How social distancing, outdoor temperatures impact the spread of COVID-19

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.

Major imaging groups launch campaign urging patients to ‘return to care’

Industry advocates such as RSNA and the American College of Radiology are concerned about recent reports of consumers putting off imaging amid fears of contracting COVID-19.

78% of COVID-19 patients show signs of heart damage after recovery

Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

CDC commits to improving COVID-19 disparities with new data-driven strategy

The agency released a document Friday outlining its approach, which also includes more testing, contact tracing, and safely quarantining, isolating and treating minorities at risk.

What new research out of Korea tells us about NSAID use and heart attacks

The authors tracked more than 108,000 patients who suffered their first heart attack between 2009 and 2013.

Clinical

Congressional candidate physician sues hospital and doctor for death of father

Diabetes reduces survival after SAVR, but not TAVR

DEA wants to permanently anchor some COVID-era prescription regulations

Brain changes related to Huntington's evident on imaging decades before symptoms emerge

Medtronic heart rhythm technologies on full display at AF Symposium 2025